OPRM1 and neoplasm: Cell proliferation (Figure 6C), migration, and invasion (Figure 6D,E) abilities were significantly enhanced by treatingMOR-silenced cells with PI3K/AKT pathway agonist SC79.These results indicate that activation of MOR downstream pathway PI3K/AKT contributes to the EMT of tumor cells.